Literature DB >> 16828711

TEL/ETV6 induces apoptosis in 32D cells through p53-dependent pathways.

Tetsuya Yamagata1, Kazuhiro Maki, Kazuo Waga, Kinuko Mitani.   

Abstract

TEL is an ETS family transcription factor that is critical for maintaining hematopoietic stem cells in adult bone marrow. To investigate the roles of TEL in myeloid proliferation and differentiation, we introduced TEL cDNA into mouse myeloid 32Dcl3 cells. Overexpression of TEL repressed interleukin-3-dependent proliferation through blocking cell cycle progression. Also, the presence of TEL triggered apoptosis through the mitochondrial intrinsic pathway on exposure to granulocyte colony-stimulating factor. We found an increase in p53 protein and its DNA binding in the TEL-overexpressing cells. Forced expression of TEL stimulated transcription via the p53-responsive element and increased the expression of cellular target genes for p53 such as cell cycle regulator p21 and apoptosis inducer Puma. Consistently, induction of apoptosis was delayed by pifithrin-alpha treatment and completely blocked by increased expression of Bcl-2 in the TEL-overexpressing cells. These data collectively suggest that TEL exerts a tumor suppressive function through augmenting the p53 pathway and facilitates normal development of myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828711     DOI: 10.1016/j.bbrc.2006.06.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  TEL/ETV6 binds to corepressor KAP1 via the HLH domain.

Authors:  Yuka Nakamura; Tetsuya Yamagata; Kazuhiro Maki; Ko Sasaki; Issay Kitabayashi; Kinuko Mitani
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Germline ETV6 mutations and predisposition to hematological malignancies.

Authors:  Simone Feurstein; Lucy A Godley
Journal:  Int J Hematol       Date:  2017-05-29       Impact factor: 2.490

3.  Low-level expression of ETV6/TEL in patients with Myelodysplastic syndrome.

Authors:  Tetsuya Yamagata; Yuka Nakamura; Kinuko Mitani
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

4.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969

5.  Combining CDKN1A gene expression and genome-wide SNPs in a twin cohort to gain insight into the heritability of individual radiosensitivity.

Authors:  Joanna Zyla; Sylwia Kabacik; Grainne O'Brien; Salma Wakil; Najla Al-Harbi; Jaakko Kaprio; Christophe Badie; Joanna Polanska; Ghazi Alsbeih
Journal:  Funct Integr Genomics       Date:  2019-01-31       Impact factor: 3.410

6.  ETV6: A Candidate Gene for Predisposition to "Blend Pedigrees"? A Case Report from the NEXT-Famly Clinical Trial.

Authors:  Simona Bernardi; Mirko Farina; Camilla Zanaglio; Federica Cattina; Nicola Polverelli; Francesca Schieppati; Federica Re; Chiara Foroni; Michele Malagola; Andrew J Dunbar; Domenico Russo
Journal:  Case Rep Hematol       Date:  2020-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.